Gene expression analyses revealed that SPDEF expression is decreased during prostate cancer progression, and there is a gradual decrease in SPDEF expression with increasing Gleason grade and a significant decrease during the transition from CRPC-Adeno to CRPC-NE. The gene discussed is SPDEF; the disease is prostate carcinoma.